World Orphan Drug Congress
Strategy, partnerships and opportunity for Pharma, Biotech, Patient Organisations and Investors
The 3rd annual World Orphan Drug Congress is Europe’s leading forum for rare disease clinical advancement and strategic partnerships and collaborations.
World Orphan Drug Congress Europe is now 3-congresses in one in 2012, combining the very best of orphan and rare disease clinical development, corporate and strategic development, market access, pricing and reimbursement.
Showcasing major global trends, industry best practice, real ‘How to’ case studies and 1-2-1 partnering opportunities, this event delivers unrivalled industry participation across the whole rare disease value chain.
EuropaBio members will receive an additional 20% discount when registering for this event